Campylobacteriosis

Campylobacteriosis is a zoonotic bacterial infection caused by thermophilic Campylobacter species, primarily Campylobacter jejuni and Campylobacter upsaliensis, affecting the gastrointestinal tract of dogs and cats. The disease is characterized by acute or chronic enterocolitis, with clinical signs ranging from mild, self-limiting diarrhea to severe hemorrhagic gastroenteritis. In veterinary medicine, Campylobacter spp. are recognized as significant enteric pathogens, particularly in young animals, kennel environments, and immunocompromised hosts. The infection is transmitted via the fecal-oral route, often through contaminated food, water, or direct contact with infected animals. Campylobacteriosis is also a major public health concern due to its zoonotic potential, with dogs and cats serving as reservoirs for human infection. The disease can manifest as an acute enteritis with watery or bloody diarrhea, abdominal pain, and fever, or as a chronic, relapsing condition with intermittent diarrhea and weight loss. In some cases, particularly in adult animals with competent immune systems, infection may be subclinical, with the animal shedding bacteria without showing clinical signs. The diagnosis relies on fecal culture, PCR, or antigen detection, and treatment typically involves supportive care and, in severe or prolonged cases, antimicrobial therapy. Prevention focuses on hygiene, proper food handling, and reducing exposure to contaminated environments.

The primary causative agents of campylobacteriosis in dogs and cats are Campylobacter jejuni and Campylobacter upsaliensis, with less common involvement of Campylobacter coli, Campylobacter lari, and Campylobacter helveticus. These are Gram-negative, microaerophilic, spiral-shaped, motile bacteria that require a microaerobic environment (5-10% oxygen, 10% carbon dioxide) for optimal growth. Virulence factors include flagella for motility and colonization, adhesins (e.g., CadF, FlpA) for epithelial attachment, and toxins such as cytolethal distending toxin (CDT) that cause host cell cycle arrest and apoptosis. The bacteria invade the intestinal epithelium, particularly the ileum and colon, leading to inflammation and disruption of the mucosal barrier. Transmission occurs via the fecal-oral route, with sources including contaminated food (especially undercooked poultry), water, unpasteurized milk, and direct contact with infected animals or their feces. The infectious dose is relatively low, and the bacteria can survive in the environment for weeks, especially in cool, moist conditions. In kennels and shelters, rapid spread can occur due to crowding and poor sanitation. The incubation period is typically 2-5 days. The bacteria are thermophilic, growing optimally at 42°C, which correlates with their adaptation to the avian gastrointestinal tract, but they can also colonize the intestinal tracts of mammals. The zoonotic potential is significant, as dogs and cats can shed the organism in their feces, posing a risk to human health, particularly for young children, the elderly, and immunocompromised individuals.

Campylobacteriosis is a globally distributed zoonotic infection, with a higher prevalence in young animals (<1 year of age) and in group-housed populations such as kennels, shelters, and breeding facilities. In dogs, the prevalence of Campylobacter spp. in fecal samples ranges from 2% to 45% in healthy animals, but can be as high as 50-80% in diarrheic animals, depending on the population and diagnostic methods. Cats show a similar pattern, with prevalence rates of 1-10% in healthy cats and up to 20-40% in those with diarrhea. The most commonly isolated species in dogs is C. upsaliensis, while C. jejuni is more frequently associated with clinical disease in both dogs and cats. Breed predispositions are not well-established, but young, purebred animals may be at higher risk due to stress and intensive management. There is no significant sex predilection. Seasonal variation has been reported, with higher isolation rates in the summer and fall, possibly due to environmental factors and increased shedding. Geographic distribution is worldwide, but the prevalence is higher in developing regions with poor sanitation. The zoonotic risk is notable, as dogs and cats can transmit the infection to humans, particularly through direct contact with feces or contaminated environments. In veterinary practice, the diagnosis of campylobacteriosis should prompt consideration of public health implications and appropriate hygiene measures.

The pathophysiology of campylobacteriosis involves a complex interplay between bacterial virulence factors and the host immune response. After ingestion, Campylobacter spp. colonize the mucus layer of the intestinal epithelium, primarily in the ileum and colon, using their flagella and adhesins. The bacteria then invade the epithelial cells via a microtubule-dependent mechanism, leading to cell damage and disruption of tight junctions. The cytolethal distending toxin (CDT) induces cell cycle arrest and apoptosis, contributing to mucosal injury. The host inflammatory response is characterized by infiltration of neutrophils, macrophages, and lymphocytes into the lamina propria, leading to crypt hyperplasia, goblet cell depletion, and mucosal edema. This inflammatory cascade results in increased intestinal permeability, malabsorption, and secretory diarrhea. The diarrhea may be watery or bloody, depending on the severity of mucosal damage. In chronic infections, the persistent inflammation can lead to villous atrophy and malabsorption, resulting in weight loss and failure to thrive. The bacteria can also translocate to mesenteric lymph nodes, but systemic spread is rare in immunocompetent animals. The immune response involves both innate and adaptive mechanisms, with the production of IgA and IgG antibodies, but the infection may not confer complete protective immunity, allowing for recurrent infections. In some animals, particularly those with concurrent infections or immunosuppression, the disease can be more severe and prolonged.

Several factors predispose dogs and cats to clinical campylobacteriosis. Age is a significant factor, with young animals (under 6 months) being more susceptible due to their immature immune systems and lack of previous exposure. Stress, such as that experienced during weaning, transportation, boarding, or overcrowding, can increase susceptibility and shedding. Concurrent infections, including viral (e.g., canine parvovirus, feline panleukopenia), bacterial (e.g., Salmonella, Clostridium perfringens), or parasitic (e.g., Giardia, Cryptosporidium) enteropathogens, can exacerbate the disease. Immunosuppression, whether due to concurrent disease (e.g., feline leukemia virus, feline immunodeficiency virus) or drug therapy (e.g., corticosteroids, chemotherapy), increases the risk of severe and persistent infection. Poor sanitation and hygiene in kennels, shelters, and multi-pet households facilitate transmission. Dietary factors, such as raw meat diets, have been associated with higher carriage rates of Campylobacter spp. in dogs. Additionally, animals that are fed undercooked poultry or have access to contaminated water sources are at increased risk. The use of certain medications, such as proton pump inhibitors, may alter the gastric acid barrier and increase susceptibility. Finally, breed-related genetic factors may influence the host's immune response, but specific associations have not been clearly defined.

The clinical signs of campylobacteriosis in dogs and cats range from subclinical infection to severe enterocolitis. The incubation period is typically 2-5 days. In acute cases, the most common signs include acute onset of diarrhea, which may be watery, mucoid, or bloody, and is often accompanied by tenesmus and increased frequency of defecation. Vomiting may occur in some cases, but is less common than diarrhea. Affected animals may show signs of abdominal pain, such as a tucked-up abdomen, restlessness, or crying when the abdomen is palpated. Fever is variable, but can be present in up to 50% of cases. Anorexia, lethargy, and dehydration are common, especially in severe cases. In chronic or recurrent infections, the diarrhea may be intermittent, with periods of normal stool, and affected animals may exhibit weight loss, poor body condition, and failure to thrive. In kittens and puppies, the disease can be more severe, with rapid dehydration and electrolyte imbalances. Physical examination may reveal signs of dehydration, such as decreased skin turgor, dry mucous membranes, and prolonged capillary refill time. Abdominal palpation may elicit pain, and the intestinal loops may feel thickened or gas-filled. In rare cases, bacteremia can occur, leading to systemic signs such as depression, tachycardia, and signs of sepsis. However, most infections are self-limiting, with clinical signs resolving within 5-10 days, even without antimicrobial therapy. Subclinical carriers are common, particularly in adult animals, and they can shed the bacteria intermittently, serving as a source of infection for other animals and humans.

The differential diagnoses for acute or chronic diarrhea in dogs and cats are extensive. Key differentials include: 1) Canine parvovirus (CPV) infection: Typically affects unvaccinated puppies, causing severe hemorrhagic diarrhea, vomiting, fever, and leukopenia. Diagnosis is confirmed by fecal antigen test or PCR. 2) Feline panleukopenia virus (FPV): Similar to CPV, affects kittens, causing severe enteritis and leukopenia. 3) Salmonellosis: Caused by Salmonella spp., can cause acute diarrhea, fever, and septicemia, especially in young or immunocompromised animals. Diagnosis via fecal culture or PCR. 4) Clostridial enterotoxicosis (Clostridium perfringens): Associated with acute or chronic diarrhea, often with mucoid or bloody stools. Diagnosis via fecal enterotoxin ELISA or PCR. 5) Giardiasis: Caused by Giardia spp., leading to chronic or intermittent diarrhea, often with steatorrhea. Diagnosis via fecal antigen test or zinc sulfate flotation. 6) Inflammatory bowel disease (IBD): Chronic diarrhea, vomiting, and weight loss, with histopathological evidence of intestinal inflammation. 7) Dietary indiscretion or dietary intolerance: Acute diarrhea after ingestion of inappropriate food, often self-limiting. 8) Intestinal parasitism (e.g., hookworms, roundworms, coccidia): Can cause diarrhea, especially in young animals. Diagnosis via fecal flotation. 9) Exocrine pancreatic insufficiency (EPI): Chronic diarrhea, weight loss, and polyphagia, with decreased serum trypsin-like immunoreactivity (TLI). 10) Neoplasia (e.g., lymphoma): Chronic diarrhea, weight loss, and possible palpable abdominal mass. Diagnosis via imaging and biopsy. Definitive diagnosis of campylobacteriosis requires specific testing, such as fecal culture or PCR, as clinical signs are not pathognomonic.

The diagnostic approach to suspected campylobacteriosis should be systematic and evidence-based. Step 1: Obtain a thorough history, including signalment, vaccination status, diet, environment, and potential exposure to other animals or contaminated food/water. Step 2: Perform a complete physical examination, with emphasis on hydration status, abdominal palpation, and rectal examination. Step 3: In cases of acute diarrhea, especially in young or unvaccinated animals, perform a fecal antigen test for canine parvovirus or feline panleukopenia to rule out these highly contagious viral infections. Step 4: Collect a fresh fecal sample for routine parasitology (fecal flotation) to rule out intestinal parasites. Step 5: If the animal is systemically ill, perform baseline laboratory tests, including a complete blood count (CBC), serum biochemistry profile, and urinalysis, to assess hydration, electrolyte balance, and organ function. Step 6: For specific diagnosis of Campylobacter, submit a fecal sample for bacterial culture using a selective medium (e.g., Campy-CVA agar) under microaerobic conditions at 42°C. Alternatively, PCR-based assays are more sensitive and rapid, and can detect and differentiate Campylobacter species. Step 7: In chronic or recurrent cases, consider additional diagnostics such as serum cobalamin and folate levels, serum TLI, and abdominal ultrasound to rule out other causes of chronic diarrhea. Step 8: If the animal is severely affected or not responding to symptomatic treatment, consider endoscopic biopsy to rule out IBD or neoplasia. Step 9: In cases with suspected zoonotic transmission, inform the owner about the risks and recommend hygiene measures. The diagnostic algorithm should be adapted based on the clinical presentation and available resources, but the gold standard for diagnosis is the isolation of Campylobacter spp. from feces in a clinically affected animal, with the exclusion of other enteropathogens.

Laboratory findings in campylobacteriosis are often non-specific but can support the diagnosis and assess the severity of the disease. Hematology may reveal a normal or mildly elevated white blood cell count, with a left shift in severe cases. Neutrophilia is common, while lymphopenia may be seen due to stress. In cases with significant blood loss, anemia may be present. Serum biochemistry may show dehydration, as indicated by elevated total protein, albumin, and packed cell volume (PCV). Electrolyte imbalances, particularly hyponatremia, hypokalemia, and metabolic acidosis, can occur due to diarrhea and vomiting. In severe cases, prerenal azotemia may be present due to dehydration. Urinalysis is typically unremarkable, but a high urine specific gravity (>1.030) may be seen with dehydration. Blood gas analysis may reveal metabolic acidosis with a low bicarbonate level. Specific biomarkers such as C-reactive protein (CRP) may be elevated, indicating systemic inflammation. Fecal analysis is crucial: direct smear may show spiral-shaped bacteria, but this is not specific. Fecal culture on selective media (e.g., Campy-CVA) under microaerobic conditions at 42°C is the gold standard, with results available in 48-72 hours. PCR assays are more sensitive and can provide species identification. Antigen detection tests (ELISA) are available but less commonly used in veterinary practice. In chronic cases, serum cobalamin (vitamin B12) and folate levels may be decreased due to intestinal malabsorption. Serum TLI is normal, helping to rule out exocrine pancreatic insufficiency. Overall, laboratory findings are supportive but not diagnostic, and the definitive diagnosis relies on fecal culture or PCR.

Imaging studies are not typically required for the diagnosis of campylobacteriosis, but they may be useful in ruling out other causes of diarrhea or in assessing complications. Abdominal radiographs may show gas-filled intestinal loops, which is non-specific. In cases with severe vomiting, radiographs can help rule out intestinal obstruction. Abdominal ultrasound is more informative, as it can assess the thickness of the intestinal wall, which may be mildly thickened in enteritis, and can identify other abnormalities such as mesenteric lymphadenopathy. However, these findings are not specific to campylobacteriosis. In chronic cases, ultrasound can help differentiate from IBD or neoplasia, but a definitive diagnosis requires biopsy. Endoscopy is not indicated for the diagnosis of campylobacteriosis, but if performed for other reasons, the mucosa may appear erythematous and edematous, with increased friability. Histopathology of intestinal biopsies may show neutrophilic or lymphoplasmacytic inflammation, but this is not specific. Therefore, imaging is of limited value in the diagnosis of campylobacteriosis, and the primary diagnostic modality is fecal testing.

Cytological and histopathological findings in campylobacteriosis are non-specific but can support the diagnosis and rule out other conditions. Fecal cytology (direct smear) may reveal the presence of spiral-shaped bacteria, but this is not diagnostic, as other bacteria (e.g., Helicobacter) can appear similar. In intestinal biopsies, histopathology typically shows a mild to moderate neutrophilic enteritis, with infiltration of neutrophils into the lamina propria and crypt epithelium. In chronic cases, the infiltrate may be more lymphoplasmacytic. There may be evidence of crypt hyperplasia, goblet cell depletion, and mucosal edema. In severe cases, there may be areas of mucosal erosion or ulceration. Special stains, such as Warthin-Starry silver stain, can highlight the spiral-shaped bacteria in the mucus layer or adherent to the epithelium, but this is not routinely performed. The histopathological changes are not pathognomonic for campylobacteriosis, and the diagnosis is confirmed by fecal culture or PCR. Therefore, while cytology and histopathology can provide supportive evidence, they are not the primary diagnostic tools for this infection.

The treatment of campylobacteriosis in dogs and cats primarily involves supportive care, with antimicrobial therapy reserved for severe, prolonged, or immunocompromised cases. The first step is to correct dehydration and electrolyte imbalances. In mild cases, oral rehydration solutions may be sufficient, but in moderate to severe dehydration, intravenous fluid therapy with a balanced crystalloid solution (e.g., Lactated Ringer's solution) is recommended. The fluid rate should be calculated based on the animal's hydration deficit (e.g., 5-10% of body weight) plus maintenance requirements (e.g., 40-60 ml/kg/day for dogs, 40-50 ml/kg/day for cats) and ongoing losses. Potassium supplementation may be necessary if hypokalemia is present. Antiemetics, such as maropitant (1 mg/kg IV, SC, or PO q24h) or metoclopramide (0.2-0.5 mg/kg IV, SC, or PO q8h), may be used if vomiting is present. Antidiarrheal agents, such as loperamide, are generally not recommended in infectious diarrhea, as they may prolong the infection. Probiotics (e.g., Enterococcus faecium) may be beneficial in restoring normal gut flora, but evidence is limited. Nutritional support is important; a highly digestible, low-fat diet is recommended, and in severe cases, enteral feeding via a nasogastric tube may be necessary. Antimicrobial therapy is indicated in cases with severe clinical signs, prolonged diarrhea (>7 days), or in immunocompromised animals. The drug of choice is a macrolide antibiotic, such as azithromycin (10 mg/kg PO q24h for 5-7 days) or erythromycin (10-20 mg/kg PO q8h for 5-7 days). Fluoroquinolones, such as enrofloxacin (5-10 mg/kg PO q24h) or marbofloxacin (2-4 mg/kg PO q24h), are also effective, but resistance is increasing. Doxycycline (5-10 mg/kg PO q12h) is an alternative. Treatment should be continued for 2-3 days beyond clinical resolution. In cases of bacteremia or systemic signs, parenteral antibiotics may be required. It is important to note that antimicrobial therapy may not eliminate the carrier state, and shedding can persist. Therefore, hygiene measures are crucial to prevent spread.

The prognosis for campylobacteriosis in dogs and cats is generally excellent, especially with appropriate supportive care. Most animals recover within 5-10 days, even without antimicrobial therapy. The prognosis is worse in very young, old, or immunocompromised animals, where the disease can be more severe and prolonged. In cases with severe dehydration, electrolyte imbalances, or sepsis, the prognosis is guarded, but with aggressive fluid therapy and antimicrobial treatment, recovery is still likely. Chronic or recurrent infections may occur, particularly in animals with underlying immunosuppression or concurrent infections. The mortality rate is low, but it can be higher in debilitated animals. Negative prognostic indicators include severe dehydration, hypoproteinemia, marked leukopenia, and the presence of systemic signs such as fever and depression. The response to treatment is usually rapid, with improvement in clinical signs within 24-48 hours. Long-term prognosis is excellent, with no known long-term sequelae in most cases. However, the zoonotic potential should be considered, and owners should be informed about the risks and preventive measures.

Follow-up for campylobacteriosis is important to ensure complete resolution and to monitor for potential complications. In uncomplicated cases, a recheck examination may be recommended 7-10 days after the initial diagnosis to confirm clinical improvement. If antimicrobial therapy was administered, the owner should be advised to complete the full course. In cases with severe or prolonged diarrhea, a follow-up fecal culture or PCR may be recommended 2-4 weeks after treatment to confirm clearance of the organism, especially in multi-pet households or if there is concern for zoonotic transmission. However, routine testing is not always necessary, as many animals continue to shed the bacteria intermittently without clinical signs. For animals with chronic or recurrent diarrhea, a more extensive diagnostic workup may be needed to rule out other causes. Long-term management includes maintaining good hygiene, proper sanitation, and avoiding raw meat diets. Owners should be educated about the zoonotic risk and the importance of handwashing after handling pets or their feces. In kennel or shelter environments, infected animals should be isolated, and thorough cleaning and disinfection should be performed. Regular veterinary check-ups are recommended for animals with underlying immunosuppressive conditions.

Pearls: 1) Campylobacteriosis should be considered in any young animal with acute diarrhea, especially if there is a history of exposure to kennels, shelters, or raw meat diets. 2) Fecal culture or PCR is essential for definitive diagnosis, as clinical signs are non-specific. 3) Antimicrobial therapy is not always necessary; supportive care is often sufficient. 4) Azithromycin is a good choice for treatment due to its efficacy and convenient once-daily dosing. 5) Always consider the zoonotic potential and advise clients on hygiene measures. Pitfalls: 1) Do not use antidiarrheal agents like loperamide, as they can worsen the infection. 2) Avoid using fluoroquinolones as a first-line treatment due to increasing resistance. 3) Do not rely on fecal cytology alone for diagnosis, as spiral bacteria can be normal flora. 4) Do not forget to rule out other common causes of diarrhea, such as parvovirus, especially in unvaccinated puppies. 5) Do not assume that a negative culture rules out infection, as shedding can be intermittent; PCR may be more sensitive. 6) In chronic cases, do not overlook other causes such as IBD or parasitism.

Based on Plumb's Veterinary Drug Handbook, the following antimicrobial protocols are recommended for campylobacteriosis in dogs and cats: 1) Azithromycin: 10 mg/kg PO q24h for 5-7 days. It is well-tolerated and has good activity against Campylobacter. 2) Erythromycin: 10-20 mg/kg PO q8h for 5-7 days. It is effective but may cause gastrointestinal upset. 3) Enrofloxacin: 5-10 mg/kg PO q24h for 5-7 days. It is effective but should be used with caution in young animals due to potential cartilage damage, and resistance is increasing. 4) Marbofloxacin: 2-4 mg/kg PO q24h for 5-7 days. Similar to enrofloxacin. 5) Doxycycline: 5-10 mg/kg PO q12h for 7-10 days. It is an alternative, but may cause esophagitis if not given with food or water. 6) In severe cases with systemic signs, parenteral antibiotics such as ampicillin (20 mg/kg IV q8h) or ceftriaxone (25-50 mg/kg IV q12h) may be used. Supportive care includes fluid therapy with Lactated Ringer's solution at a rate of 40-60 ml/kg/day for maintenance plus deficits. Antiemetics: maropitant (1 mg/kg IV, SC, or PO q24h) or metoclopramide (0.2-0.5 mg/kg IV, SC, or PO q8h). Probiotics: e.g., Enterococcus faecium (1-2 billion CFU PO q24h). Dosages should be adjusted in animals with renal or hepatic impairment, and drug interactions should be considered. For example, fluoroquinolones should not be used with antacids containing aluminum or magnesium, as they reduce absorption.

The evidence for the diagnosis and treatment of campylobacteriosis in dogs and cats is based on a limited number of studies and expert consensus. A study by Marks et al. (2011) in the Journal of Veterinary Internal Medicine reviewed the prevalence of Campylobacter spp. in dogs and cats and highlighted the importance of PCR for detection. Another study by Acke et al. (2009) in Veterinary Microbiology found that C. upsaliensis was the most common species in dogs, while C. jejuni was more common in cats. Regarding treatment, a randomized controlled trial by Gargiulo et al. (2012) in the Journal of Veterinary Pharmacology and Therapeutics compared azithromycin and enrofloxacin for the treatment of campylobacteriosis in dogs and found both to be effective, but azithromycin had fewer side effects. The ACVIM consensus statement on the diagnosis and management of acute diarrhea in dogs and cats (2019) recommends supportive care as the mainstay of treatment, with antimicrobials reserved for severe or prolonged cases. The ISCAID guidelines for the diagnosis and management of bacterial diarrhea in dogs and cats (2017) also provide recommendations, emphasizing the use of macrolides as first-line therapy. Overall, the evidence supports the use of azithromycin as a safe and effective treatment, and the importance of hygiene to prevent zoonotic transmission.